Jul. 1, 2020—Chancellor Daniel Diermeier reflects on the challenges of the moment, his plans for the university, and his optimism for its future in a message to the Vanderbilt community.
Jul. 1, 2020—Vanderbilt University's new chancellor, Daniel Diermeier, is arriving on campus in the midst of national upheaval. (SUBSCRIPTION REQUIRED)
Jul. 1, 2020—The Vanderbilt community is delighted to welcome Daniel Diermeier on July 1, 2020, as the university’s ninth chancellor.
Jul. 1, 2020—Daniel Diermeier greets the Vanderbilt community and shares his optimism in the university’s future on his first official day as chancellor.
Jun. 29, 2020—Members of the Vanderbilt community pay tribute to Susan R. Wente for guiding the university—with visionary strength and compassion—during her time as interim chancellor.
Jun. 29, 2020—Susan R. Wente is being thanked across campus for her exceptional leadership during an unprecedented year, as her tenure as interim chancellor concludes and she returns full-time as provost July 1.
Jun. 29, 2020—The Vanderbilt Board of Trust pays tribute to Interim Chancellor and Provost Susan R. Wente with a resolution and appoints her Cornelius Vanderbilt Chair.
Jun. 29, 2020—Research Scholar Grants are one of Vanderbilt’s primary investments to advance faculty research, scholarship and creative expression, while Discovery Grants support new ideas and cutting-edge scholarship that possess high potential for future external support.
Jun. 19, 2020—Vanessa Beasley’s role as vice provost for academic affairs is expanding with oversight of four additional areas integral to the undergraduate education experience.
Jun. 17, 2020—Interim Chancellor and Provost Susan R. Wente and Vice Chancellor for Administration Eric Kopstain will host a virtual town hall for staff on Monday, June 22, at 11:30 a.m. to discuss the university’s Return to Campus Plan. A second town hall for faculty is planned for Wednesday, June 24, at 11 a.m.
Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders
Jun. 16, 2020—Vanderbilt University’s Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc. to develop treatments for disorders like Alzheimer’s and schizophrenia.
Jun. 16, 2020—All incoming and current Vanderbilt students and their families are invited to learn more about the university’s Return to Campus Plan at a virtual town hall tomorrow. The live session will take place on Saturday, June 20, at 10 a.m.